Skip to main content
Top
Published in: International Ophthalmology 1/2020

Open Access 01-01-2020 | Glaucoma | Original Paper

Efficacy of postoperative management with 5-fluorouracil injections after XEN Gel Stent implantation

Authors: Ewa Wałek, Joanna Przeździecka-Dołyk, Iwona Helemejko, Marta Misiuk-Hojło

Published in: International Ophthalmology | Issue 1/2020

Login to get access

Abstract

Purpose

To evaluate the efficacy of postoperative management with 5-fluorouracil injections after XEN Gel Stent implantation.

Methods

Prospective real-world evidence study included 39 eyes (of 36 patients) with primary open-angle glaucoma without previous glaucoma surgery and with uncontrolled intraocular pressure (IOP), glaucoma progression, or intolerance to IOP-lowering therapy. Patients underwent mitomycin C-augmented XEN implantation either as a stand-alone procedure or combined with cataract extraction. 5-Fluorouracil subconjunctival injections were a first-choice therapy for bleb failure and were administered according to predetermined criteria (analogous to pro re nata regimen in age-related macular degeneration treatment). Primary outcome was unqualified success, defined as postoperative IOP < 18 mmHg and > 20% reduction from medicated baseline without any antiglaucoma medications and no detected glaucoma progression.

Results

At median follow-up of 8 months (range 3–24 months), IOP decreased from a medicated baseline value of 23 mmHg (95% CI 21–24 mmHg) to 13 mmHg (95% CI 12–15 mmHg) and number of medications decreased from 3 (95% CI 2–3) to 0 (p < 0.0001 for both). Median number of 5-fluorouracil injections per eye was 3 (95% CI 2–3), and median time to first injection was 0.5 months (95% CI 0.25–3 months) after surgery. Thirteen eyes (33.3%) underwent ≥ 1 needling, and surgical revision was performed in three cases (7.7%). The primary outcome measure, which allows performing additional procedures, was achieved in 27 eyes (69%).

Conclusions

5-Fluorouracil subconjunctival injections are safe and effective in postoperative management of bleb failure after XEN implantation and represent a viable alternative to other methods.
Appendix
Available only for authorised users
Literature
2.
go back to reference Vera VI, Horvath C (2014) XEN Gel Stent: the solution designed by AqueSys®. In: Samples JR, Ahmed IIK (eds) Surgical innovations in glaucoma. Springer, New York, pp 189–198CrossRef Vera VI, Horvath C (2014) XEN Gel Stent: the solution designed by AqueSys®. In: Samples JR, Ahmed IIK (eds) Surgical innovations in glaucoma. Springer, New York, pp 189–198CrossRef
11.
go back to reference Olivari S, Negri L, Cuttolo CA et al (2018) XEN fracture after needling procedure. European glaucoma society congress, Florence 2018, Abstract book, p 61 Olivari S, Negri L, Cuttolo CA et al (2018) XEN fracture after needling procedure. European glaucoma society congress, Florence 2018, Abstract book, p 61
14.
go back to reference Shaarawy TM, Sherwood MB, Grehn F (2009) WGA guidelines on design and reporting glaucoma trials. Kugler Publications, Amsterdam Shaarawy TM, Sherwood MB, Grehn F (2009) WGA guidelines on design and reporting glaucoma trials. Kugler Publications, Amsterdam
Metadata
Title
Efficacy of postoperative management with 5-fluorouracil injections after XEN Gel Stent implantation
Authors
Ewa Wałek
Joanna Przeździecka-Dołyk
Iwona Helemejko
Marta Misiuk-Hojło
Publication date
01-01-2020
Publisher
Springer Netherlands
Keyword
Glaucoma
Published in
International Ophthalmology / Issue 1/2020
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-019-01168-8

Other articles of this Issue 1/2020

International Ophthalmology 1/2020 Go to the issue